FMR CORP 13D/13G Filings for TG Therapeutics, Inc. (TGTX)

FMR CORP 13D and 13G filings for TG Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-09
12:39 pm
Sale		 2023-02-09 13G TG Therapeutics, Inc.
TGTX		 FMR CORP 7,188,862
4.946%		 -865,599decrease
(-10.75%)		 Filing
2022-07-11
08:49 am
Sale		 2022-07-08 13G TG Therapeutics, Inc.
TGTX		 FMR CORP 8,054,461
5.576%		 -12,666,970decrease
(-61.13%)		 Filing
2022-02-09
10:01 am
Purchase		 2022-02-08 13G TG Therapeutics, Inc.
TGTX		 FMR CORP 20,721,431
14.496%		 5,894,295increase
(+39.75%)		 Filing
2021-02-08
10:33 am
Purchase		 2021-02-05 13G TG Therapeutics, Inc.
TGTX		 FMR CORP 14,827,136
10.963%		 2,179,411increase
(+17.23%)		 Filing
2020-06-10
10:13 am
Purchase		 2020-06-09 13G TG Therapeutics, Inc.
TGTX		 FMR CORP 12,647,725
10.658%		 9,924,288increase
(+364.40%)		 Filing